2929 ARCH STREET, PHILADELPHIA, PA
Other Events
Reports Second Quarter 2026 Financial Results and Provides Business Update
Cabaletta Bio, Inc. Increases Authorized Shares to 600 Million
Investor Presentation
Reports First Quarter 2026 Financial Results and Provides Business Update
Cabaletta Bio Presents New Data from RESET-PV Trial at ASGCT 2026
Q2
Q1
FY 2025
Q3
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Correspondence
Submission Upload